AngioDynamics Reports Better-Than-Expected GAAP EPS and Revenue Growth
AngioDynamics (ANGO) reported Q4 2026 results with a GAAP EPS of -$0.07, beating estimates by $0.11, while revenue reached $86.61M, up 8% year-over-year and exceeding expectations by $6.37M. The company provided guidance for FY26 net sales between $336.0M to $341.0M with adjusted EBITDA expected in the range of $13.0M to $16.0M.
Tickers: $ANGO
Topics: Earnings Guidance Revenue Beat